Literature DB >> 14564100

Cochlear implantation after acoustic tumour resection in neurofibromatosis type 2: impact of intra- and postoperative neural response telemetry monitoring.

C Nölle1, I Todt, D Basta, A Unterberg, V F Mautner, A Ernst.   

Abstract

The present paper reports about a 16-year-old male with neurofibromatosis type 2 (NF-2) of the Wishart type with bilateral deafness who had undergone cochlear implantation after resection of the acoustic neuroma (AN) of the same side. Neural response telemetry (NRT) recordings are essential in those patients during cochlear implantation where no stapedial reflexes can be electrically elicited due to the resection of the AN. In the present case, amplitude growth function and a type II pattern of the NRT waveforms could be well established. The comparison of the N(1) response intra-operatively and after 2 years showed a decline in latency by 50% and an increase in absolute amplitude by 10 times at the same current level of electrical stimulation. This improved auditory nerve transduction suggested a change to a 'faster' encoding strategy to improve speech understanding. The change from SPEAK to ACE 18 months after the operation led to an increase in the open-set sentence recognition test from 52 to 88%. Thus, NRT recordings monitor the intra-operative success of electrode placement and help to assess the integrity of the auditory pathway. Moreover, they can reliably be used in programming the speech processor postoperatively as objective tool. In patients with NF-2, the restoration of hearing can be successfully achieved in several ways. The indications for hearing implants (auditory brain stem and cochlear implants) should be carefully considered with respect to the remaining, functional integrity of the auditory nerve and the technical possibilities to monitor the success of these procedures. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 14564100     DOI: 10.1159/000073122

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  7 in total

1.  Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants.

Authors:  Pamela C Roehm; Jon Mallen-St Clair; Daniel Jethanamest; John G Golfinos; William Shapiro; Susan Waltzman; J Thomas Roland
Journal:  J Neurosurg       Date:  2011-07-15       Impact factor: 5.115

Review 2.  The emerging role of hearing loss rehabilitation in patients with vestibular schwannoma treated with Gamma Knife radiosurgery: literature review.

Authors:  Carlotta Morselli; N Boari; M Artico; M Bailo; L O Piccioni; I Giallini; M de Vincentiis; P Mortini; P Mancini
Journal:  Neurosurg Rev       Date:  2020-02-06       Impact factor: 3.042

3.  Cochlear Implantation in Vestibular Schwannoma: A Systematic Literature Review.

Authors:  Kent Tadokoro; Matthew Robert Bartindale; Nadeem El-Kouri; Dennis Moore; Christopher Britt; Matthew Kircher
Journal:  J Neurol Surg B Skull Base       Date:  2021-06-08

4.  Cochlear implantation in patients with neurofibromatosis type 2 and patients with vestibular schwannoma in the only hearing ear.

Authors:  Erika Celis-Aguilar; Luis Lassaletta; Javier Gavilán
Journal:  Int J Otolaryngol       Date:  2012-02-28

5.  Retrolabyrinthine approach for cochlear nerve preservation in neurofibromatosis type 2 and simultaneous cochlear implantation.

Authors:  Ricardo Ferreira Bento; Tatiana Alves Monteiro; Aline Gomes Bittencourt; Maria Valeria Schmidt Goffi-Gomez; Rubens de Brito
Journal:  Int Arch Otorhinolaryngol       Date:  2013-07

6.  Ipsilateral Vestibular Schwannoma after Cochlear Implantation.

Authors:  S Tüpker; N Ay; L U Scholtz; H B Gehl; V F Mautner; P Goon; H Sudhoff; I Todt
Journal:  Case Rep Otolaryngol       Date:  2022-02-18

Review 7.  Neurofibromatosis 2: hearing restoration options.

Authors:  Tatiana Alves Monteiro; Maria Valeria Schmidt Goffi-Gomez; Robinson Koji Tsuji; Marcos Queiroz Telas Gomes; Rubens Vuono Brito Neto; Ricardo Ferreira Bento
Journal:  Braz J Otorhinolaryngol       Date:  2012-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.